594 related articles for article (PubMed ID: 12473584)
21. Patterns of gene promoter methylation in squamous cell cancer of the head and neck.
Hasegawa M; Nelson HH; Peters E; Ringstrom E; Posner M; Kelsey KT
Oncogene; 2002 Jun; 21(27):4231-6. PubMed ID: 12082610
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma.
Hsu HS; Chen TP; Hung CH; Wen CK; Lin RK; Lee HC; Wang YC
Cancer; 2007 Nov; 110(9):2019-26. PubMed ID: 17876837
[TBL] [Abstract][Full Text] [Related]
23. Similar DNA methylation pattern in lung tumours from smokers and never-smokers with second-hand tobacco smoke exposure.
Scesnaite A; Jarmalaite S; Mutanen P; Anttila S; Nyberg F; Benhamou S; Boffetta P; Husgafvel-Pursiainen K
Mutagenesis; 2012 Jul; 27(4):423-9. PubMed ID: 22217548
[TBL] [Abstract][Full Text] [Related]
24. Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers.
Koga Y; Kitajima Y; Miyoshi A; Sato K; Kitahara K; Soejima H; Miyazaki K
Ann Surg Oncol; 2005 May; 12(5):354-63. PubMed ID: 15915369
[TBL] [Abstract][Full Text] [Related]
25. Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients.
Harden SV; Tokumaru Y; Westra WH; Goodman S; Ahrendt SA; Yang SC; Sidransky D
Clin Cancer Res; 2003 Apr; 9(4):1370-5. PubMed ID: 12684406
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic inactivation of Homeobox A5 gene in nonsmall cell lung cancer and its relationship with clinicopathological features.
Kim DS; Kim MJ; Lee JY; Lee SM; Choi JY; Yoon GS; Na YK; Hong HS; Kim SG; Choi JE; Lee SY; Park JY
Mol Carcinog; 2009 Dec; 48(12):1109-15. PubMed ID: 19554572
[TBL] [Abstract][Full Text] [Related]
27. Promoter hypermethylation of p16INK4a, E-cadherin, O6-MGMT, DAPK and FHIT in adenocarcinomas of the esophagus, esophagogastric junction and proximal stomach.
Schildhaus HU; Kröckel I; Lippert H; Malfertheiner P; Roessner A; Schneider-Stock R
Int J Oncol; 2005 Jun; 26(6):1493-500. PubMed ID: 15870861
[TBL] [Abstract][Full Text] [Related]
28. O(6)-Methylguanine-DNA methyltransferase promoter hypermethylation shifts the p53 mutational spectrum in non-small cell lung cancer.
Wolf P; Hu YC; Doffek K; Sidransky D; Ahrendt SA
Cancer Res; 2001 Nov; 61(22):8113-7. PubMed ID: 11719438
[TBL] [Abstract][Full Text] [Related]
29. Hypermethylation of multiple genes in tumor tissues and voided urine in urinary bladder cancer patients.
Chan MW; Chan LW; Tang NL; Tong JH; Lo KW; Lee TL; Cheung HY; Wong WS; Chan PS; Lai FM; To KF
Clin Cancer Res; 2002 Feb; 8(2):464-70. PubMed ID: 11839665
[TBL] [Abstract][Full Text] [Related]
30. Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer.
Toyooka S; Maruyama R; Toyooka KO; McLerran D; Feng Z; Fukuyama Y; Virmani AK; Zochbauer-Muller S; Tsukuda K; Sugio K; Shimizu N; Shimizu K; Lee H; Chen CY; Fong KM; Gilcrease M; Roth JA; Minna JD; Gazdar AF
Int J Cancer; 2003 Jan; 103(2):153-60. PubMed ID: 12455028
[TBL] [Abstract][Full Text] [Related]
31. Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung.
Kim JS; Kim H; Shim YM; Han J; Park J; Kim DH
Carcinogenesis; 2004 Nov; 25(11):2165-71. PubMed ID: 15231689
[TBL] [Abstract][Full Text] [Related]
32. Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma.
Hibi K; Taguchi M; Nakayama H; Takase T; Kasai Y; Ito K; Akiyama S; Nakao A
Clin Cancer Res; 2001 Oct; 7(10):3135-8. PubMed ID: 11595706
[TBL] [Abstract][Full Text] [Related]
33. Hypermethylation of multiple genes in pancreatic adenocarcinoma.
Ueki T; Toyota M; Sohn T; Yeo CJ; Issa JP; Hruban RH; Goggins M
Cancer Res; 2000 Apr; 60(7):1835-9. PubMed ID: 10766168
[TBL] [Abstract][Full Text] [Related]
34. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
Yanagawa N; Tamura G; Oizumi H; Kanauchi N; Endoh M; Sadahiro M; Motoyama T
Lung Cancer; 2007 Oct; 58(1):131-8. PubMed ID: 17606310
[TBL] [Abstract][Full Text] [Related]
35. [Value of promoter methylation of RASSF1A, p16, and DAPK genes in induced sputum in diagnosing lung cancers].
Peng Z; Shan C; Wang H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Mar; 35(3):247-53. PubMed ID: 20360646
[TBL] [Abstract][Full Text] [Related]
36. Analysis of promoter hypermethylation of death-associated protein kinase and p16 tumor suppressor genes in actinic keratoses and squamous cell carcinomas of the skin.
Tyler LN; Ai L; Zuo C; Fan CY; Smoller BR
Mod Pathol; 2003 Jul; 16(7):660-4. PubMed ID: 12861061
[TBL] [Abstract][Full Text] [Related]
37. [Relationship between promoter methylation of p16, DAPK and RAR beta genes and the clinical data of non-small cell lung cancer].
Zhang CY; Jin YT; Xu HY; Zhang H; Zhang WM; Sun XY; Tan C; Chen CM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Feb; 28(1):23-8. PubMed ID: 21287504
[TBL] [Abstract][Full Text] [Related]
38. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K
Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757
[TBL] [Abstract][Full Text] [Related]
39. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients.
Sanchez-Cespedes M; Esteller M; Wu L; Nawroz-Danish H; Yoo GH; Koch WM; Jen J; Herman JG; Sidransky D
Cancer Res; 2000 Feb; 60(4):892-5. PubMed ID: 10706101
[TBL] [Abstract][Full Text] [Related]
40. Plutonium targets the p16 gene for inactivation by promoter hypermethylation in human lung adenocarcinoma.
Belinsky SA; Klinge DM; Liechty KC; March TH; Kang T; Gilliland FD; Sotnic N; Adamova G; Rusinova G; Telnov V
Carcinogenesis; 2004 Jun; 25(6):1063-7. PubMed ID: 14742312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]